SCHEMBL9142199

SCHEMBL9142199

COC(=O)c1c(SC(C)C)c2cc(OC)ccc2n1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.48
PABPC1 P11940 1/20 0.47
EIF4H Q15056 1/20 0.47
TUBB4A P04350 2/20 0.45
TUBB P07437 2/20 0.45
TUBA3C P0DPH7 2/20 0.45
TUBA1B P68363 2/20 0.45
TUBA4A P68366 2/20 0.45
TUBB4B P68371 2/20 0.45
TUBB3 Q13509 2/20 0.45
TUBB2A Q13885 2/20 0.45
TUBB8 Q3ZCM7 2/20 0.45
TUBA3E Q6PEY2 2/20 0.45
TUBA1A Q71U36 2/20 0.45
TUBA1C Q9BQE3 2/20 0.45
TUBB6 Q9BUF5 2/20 0.45
TUBB2B Q9BVA1 2/20 0.45
TUBB1 Q9H4B7 2/20 0.45
MAPT P10636 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9144162 0.88 SMN1; SMN2 (0.43) L3MBTL1MAPTSMN1; SMN2KDM4EMEN1
SCHEMBL9141429 0.86 L3MBTL1 (0.51) L3MBTL1PABPC1EIF4HTUBB4ATUBB
SCHEMBL5659192 0.79 L3MBTL1 (0.55) L3MBTL1PABPC1EIF4HTUBB4ATUBB
SCHEMBL9537227 0.79 L3MBTL1 (0.49) L3MBTL1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL9146147 0.77 KDM4E (0.53) MAPTSMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL9142952 0.77 L3MBTL1 (0.47) L3MBTL1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL9540898 0.75 KDM4E (0.57) MAPTSMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL6456184 0.74 KDM4E (0.49) L3MBTL1MAPTSMN1; SMN2KDM4EMEN1
SCHEMBL11530508 0.73 KDM4E (0.68) L3MBTL1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL9146495 0.73 NMT1 (0.62) L3MBTL1SMN1; SMN2MEN1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5424329-A Administering an antiinflammatory agent to prevent leukocytes bonding to vascular endothelium, treating rheumatoid arthritis , asthma, psoriasis and AIDS WARNER-LAMBERT COMPANY (US) 1995-06-13 US disclosed